At the European Molecular Imaging Meeting (EMIM) 2026, held in Bilbao and organized by the European Society for Molecular Imaging, QT Sense engaged with a scientific community focused on visualizing and understanding biological processes in space and time. The conference theme emphasized innovation in molecular imaging technologies and their role in translational research. Representing QT Sense, Hoang, Chief Operating Officer, and Elkin, Application Scientist, presented a poster on mitochondrial-targeted drug discovery using Quantum Nuova, while also participating in exhibition activities.
Mitochondrial function is central to cellular metabolism and drug response, particularly through the regulation of reactive oxygen species. While imaging technologies provide detailed spatial information, discussions at EMIM underscored their limitations in capturing quantitative functional dynamics. Quantum Nuova complements these approaches by directly measuring free radical kinetics in real time, enabling researchers to observe how mitochondrial activity evolves under therapeutic intervention. This combination of spatial and functional insight represents a powerful new paradigm for studying complex biological systems. QT Sense was perceived as contributing a critical missing dimension to molecular imaging, bridging visualization with quantitative biochemical measurement.
